BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11724859)

  • 1. Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals.
    Ike Y; Arakawa Y; Ma X; Tatewaki K; Nagasawa M; Tomita H; Tanimoto K; Fujimoto S
    J Clin Microbiol; 2001 Dec; 39(12):4445-51. PubMed ID: 11724859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.
    Hiramatsu K; Aritaka N; Hanaki H; Kawasaki S; Hosoda Y; Hori S; Fukuchi Y; Kobayashi I
    Lancet; 1997 Dec; 350(9092):1670-3. PubMed ID: 9400512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
    Cartolano GL; Cheron M; Benabid D; Leneveu M; Boisivon A;
    Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates.
    Hussain FM; Boyle-Vavra S; Shete PB; Daum RS
    J Infect Dis; 2002 Sep; 186(5):661-7. PubMed ID: 12195353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
    Tiwari HK; Sen MR
    BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.
    Trakulsomboon S; Danchaivijitr S; Rongrungruang Y; Dhiraputra C; Susaemgrat W; Ito T; Hiramatsu K
    J Clin Microbiol; 2001 Feb; 39(2):591-5. PubMed ID: 11158112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital.
    Sancak B; Ercis S; Menemenlioglu D; Colakoglu S; Hasçelik G
    J Antimicrob Chemother; 2005 Sep; 56(3):519-23. PubMed ID: 16046461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.
    Nonhoff C; Denis O; Struelens MJ
    Clin Microbiol Infect; 2005 Mar; 11(3):214-20. PubMed ID: 15715719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in Korea.
    Kim HB; Park WB; Lee KD; Choi YJ; Park SW; Oh MD; Kim EC; Choe KW
    J Clin Microbiol; 2003 Jun; 41(6):2279-81. PubMed ID: 12791836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of vancomycin-intermediate-resistant Staphylococcus aureus in Japan.
    Hanaki H; Hososaka Y; Yanagisawa C; Otsuka Y; Nagasawa Z; Nakae T; Sunakawa K
    J Infect Chemother; 2007 Apr; 13(2):118-21. PubMed ID: 17458681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide surveillance study of vancomycin intermediate Staphylococcus aureus strains in Korean hospitals from 2001 to 2006.
    Chung G; Cha J; Han S; Jang H; Lee K; Yoo J; Yoo J; Kim H; Eun S; Kim B; Park O; Lee Ys
    J Microbiol Biotechnol; 2010 Mar; 20(3):637-42. PubMed ID: 20372039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Intermediately Vancomycin-Susceptible and Vancomycin-Heteroresistant Staphylococcus aureus by Use of Vancomycin-Supplemented Brain Heart Infusion Agar Biplates: Defining Growth Interpretation Criteria Based on Gold Standard Confirmation.
    Khatib R; Riederer K; Sharma M; Shemes S; Iyer SP; Szpunar S
    J Clin Microbiol; 2015 Nov; 53(11):3543-6. PubMed ID: 26311860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureus.
    Fitzgibbon MM; Rossney AS; O'Connell B
    J Clin Microbiol; 2007 Oct; 45(10):3263-9. PubMed ID: 17687008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of heteroresistant vancomycin intermediate Staphylococcus aureus among MRSA isolates.
    Gazel D; Erinmez M; Büyüktaş Manay A; Zer Y
    J Infect Dev Ctries; 2021 Jan; 15(1):89-94. PubMed ID: 33571150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan.
    Hiramatsu K
    Am J Med; 1998 May; 104(5A):7S-10S. PubMed ID: 9684652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinical implications of Staphylococcus aureus with a vancomycin MIC of 4 microg/ml in Korea.
    Kim HB; Lee YS; Kim BS; Cha JO; Kwon SU; Lee HJ; Suh JT; Rheem I; Kim JM; Shin BM; Kim MN; Lee K; Lee CS; Kim EC; Oh MD; Choe KW
    Microb Drug Resist; 2006; 12(1):33-8. PubMed ID: 16584306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide surveillance of resistance rates of Staphylococcus aureus clinical isolates from Greek hospitals, 2012-2013.
    Souli M; Karaiskos I; Galani L; Maraki S; Perivolioti E; Argyropoulou A; Charissiadou A; Zachariadou L; Tsiplakou S; Papaioannou V; Tsorlini H; Katsifa H; Baka V; Pantazi P; Paschali A; Kyratsa A; Trikka-Graphakos E; Giannopoulou P; Vogiatzakis E; Moraitou H; Papadogeorgaki H; Avgerinou H; Panagea T; Pantazatou A; Petinaki E; Stamatopoulou G; Toutouza M; Karatzoglou I; Kontopoulou K; Orfanidou M; Karantani I; Fytas P; Tzanetou K; Platsouka E; Kazila P; Chli A; Statiri N; Giamarellou H
    Infect Dis (Lond); 2016 Apr; 48(4):287-292. PubMed ID: 26635179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prospective study of Staphylococcus aureus with reduced susceptibility to glycopeptides].
    Cantón R; Mir N; Martínez-Ferrer M; Sánchez del Saz B; Soler I; Baquero F
    Rev Esp Quimioter; 1999 Mar; 12(1):48-53. PubMed ID: 10896469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.
    Alós JI; García-Cañas A; García-Hierro P; Rodríguez-Salvanés F
    J Antimicrob Chemother; 2008 Oct; 62(4):773-5. PubMed ID: 18552338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin.
    Song JH; Hiramatsu K; Suh JY; Ko KS; Ito T; Kapi M; Kiem S; Kim YS; Oh WS; Peck KR; Lee NY;
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4926-8. PubMed ID: 15561884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.